T F Müller1, S O Grebe, M C Neumann
1Department of Nephrology, Philipps-University of Marburg, Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Long-term immunosuppression with antithymocyte globulin (ATG) in kidney transplant patients significantly alters T-cell subsets. ATG therapy causes dose-dependent, persistent decreases in CD4+ T-cells and increases in CD8+ T-cells for years post-transplant.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: